Evidence map›Paper›PMID 24584089›Full record

ArticleNature immunology2014

Quantitative proteomics analysis of signalosome dynamics in primary T cells identifies the surface receptor CD6 as a Lat adaptor-independent TCR signaling hub.

Romain Roncagalli, Simon Hauri, Fréderic Fiore, Yinming Liang, Zhi Chen, Amandine Sansoni, Kartiek Kanduri, Rachel Joly, Aurélie Malzac, Harri Lähdesmäki and 7 more

Open access · greenAbstract read
In one paragraph

Article in Nature immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 121 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. CD6-mediated inhibition of T cell activation via modulation of Ras.Cell communication and signaling : CCS · 2022
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 4 countries.

Romain Roncagalli *Centre d'Immunologie de Marseille-Luminy, UM2 Aix-Marseille Université, Marseille, France.
Simon Hauri *Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.
Fréderic FioreCentre d'Immunophénomique, UM2 Aix-Marseille Université, Marseille, France.
Yinming LiangCentre d'Immunologie de Marseille-Luminy, UM2 Aix-Marseille Université, Marseille, France.
Zhi ChenTurku Centre for Biotechnology, University of Turku and Abo Akademi University, Turku, Finland.
Amandine SansoniCentre d'Immunophénomique, UM2 Aix-Marseille Université, Marseille, France.
Kartiek KanduriTurku Centre for Biotechnology, University of Turku and Abo Akademi University, Turku, Finland.
Rachel JolyCentre d'Immunologie de Marseille-Luminy, UM2 Aix-Marseille Université, Marseille, France.
Aurélie MalzacCentre d'Immunologie de Marseille-Luminy, UM2 Aix-Marseille Université, Marseille, France.
Harri LähdesmäkiTurku Centre for Biotechnology, University of Turku and Abo Akademi University, Turku, Finland.
Riitta LahesmaaTurku Centre for Biotechnology, University of Turku and Abo Akademi University, Turku, Finland.
Sho YamasakiDivision of Molecular Immunology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
Takashi SaitoRIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan.
Marie MalissenCentre d'Immunologie de Marseille-Luminy, UM2 Aix-Marseille Université, Marseille, France.
Ruedi AebersoldDepartment of Biology, Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.
Matthias GstaigerDepartment of Biology, Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.
Bernard MalissenCentre d'Immunologie de Marseille-Luminy, UM2 Aix-Marseille Université, Marseille, France.
Aix-Marseille Université · FRETH Zurich · CHÅbo Akademi University · FICentre d’Immunologie de Marseille-Luminy · FRUniversity of Turku · FICentre National de la Recherche Scientifique · FRKyushu University · JPRIKEN Center for Integrative Medical Sciences · JP

Funding

European Research Council 322465
6 · The paper itself

Abstract

T cell antigen receptor (TCR)-mediated activation of T cells requires the interaction of dozens of proteins. Here we used quantitative mass spectrometry and activated primary CD4(+) T cells from mice in which a tag for affinity purification was knocked into several genes to determine the composition and dynamics of multiprotein complexes that formed around the kinase Zap70 and the adaptors Lat and SLP-76. Most of the 112 high-confidence time-resolved protein interactions we observed were previously unknown. The surface receptor CD6 was able to initiate its own signaling pathway by recruiting SLP-76 and the guanine nucleotide-exchange factor Vav1 regardless of the presence of Lat. Our findings provide a more complete model of TCR signaling in which CD6 constitutes a signaling hub that contributes to the diversification of TCR signaling.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsAntigens, CDAntigens, Differentiation, T-LymphocyteCalcium SignalingCD4-Positive T-LymphocytesCells, CulturedMembrane ProteinsMiceMice, Inbred C57BLMice, TransgenicMultiprotein ComplexesPhosphoproteinsProtein BindingProteomicsProto-Oncogene Proteins c-vavAdaptor Proteins, Signal TransducingAntigens, CDAntigens, Differentiation, T-LymphocyteCD6 antigenLat protein, mouseMembrane ProteinsMultiprotein ComplexesPhosphoproteinsProto-Oncogene Proteins c-vavReceptors, Antigen, T-CellSLP-76 signal Transducing adaptor proteinsVav1 protein, mouseZap70 protein, mouseZAP-70 Protein-Tyrosine Kinase

Identifiers

PMID24584089
PMCPMC4037560
OpenAlexW2057024012

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.